| Product NDC: | 10812-131 |
| Proprietary Name: | Neutrogena Men Triple Protect Face |
| Non Proprietary Name: | Ensulizole, Octinoxate, and Oxybenzone |
| Active Ingredient(s): | 10; 60; 20 mg/mL; mg/mL; mg/mL & nbsp; Ensulizole, Octinoxate, and Oxybenzone |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | LOTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 10812-131 |
| Labeler Name: | Neutrogena Corporation |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part352 |
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Start Marketing Date: | 20111201 |
| Package NDC: | 10812-131-10 |
| Package Description: | 1 TUBE in 1 CARTON (10812-131-10) > 50 mL in 1 TUBE |
| NDC Code | 10812-131-10 |
| Proprietary Name | Neutrogena Men Triple Protect Face |
| Package Description | 1 TUBE in 1 CARTON (10812-131-10) > 50 mL in 1 TUBE |
| Product NDC | 10812-131 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Ensulizole, Octinoxate, and Oxybenzone |
| Dosage Form Name | LOTION |
| Route Name | TOPICAL |
| Start Marketing Date | 20111201 |
| Marketing Category Name | OTC MONOGRAPH NOT FINAL |
| Labeler Name | Neutrogena Corporation |
| Substance Name | ENSULIZOLE; OCTINOXATE; OXYBENZONE |
| Strength Number | 10; 60; 20 |
| Strength Unit | mg/mL; mg/mL; mg/mL |
| Pharmaceutical Classes |